Information  X 
Enter a valid email address

Xenetic Biosciences (XEN)

  Print      Mail a friend

Tuesday 20 March, 2012

Xenetic Biosciences

Amendment Holding(s) in Company

RNS Number : 7230Z
Xenetic Biosciences PLC
20 March 2012
 

 




TR:1-NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Xenetic Biosciences

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

Klaus Faber AG

4. Full name of shareholder(s)
 (if different from 3.):iv

 

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

17 January 2012

6. Date on which issuer notified:

16 March 2012

7. Threshold(s) that is/are crossed or
reached:
vi, vii

3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

In-

Direct

Ord GBP0.005

0

0

 

15,506,210

 

15,506,210

 

 

3.80%


ISIN GB00B08NWV55

 


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,506,210

3.80%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A



13. Additional information:


Based on shares in issue of 379,732,255.

14. Contact name:

Brad Marcus

15. Contact telephone number:

020 7691 3582

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLJMMATMBMTBPT